To change practice, we should move beyond trial-based efficacy to real-world effectiveness
Meaningful health care reform requires robust evidence about which interventions work best for whom and under what circumstances. The Institute of Medicine in the United States has estimated that less than 50% of current treatments are supported by evidence and 30% of health care expenditure reflects care that is of uncertain value.1 In studies testing established clinical standards of care, more than half reported evidence that contradicts standard care or is inconclusive.2 Many Medicare Benefits Schedule services lack comprehensive evidence of comparative safety or effectiveness, while many that have been evaluated have been shown to be ineffective, harmful or of uncertain value compared with alternative forms of care.3
The full article is accessible to AMA members and paid subscribers. Login to read more or purchase a subscription now.
Please note: institutional and Research4Life access to the MJA is now provided through Wiley Online Library.
- 1. Institute of Medicine (US). Learning what works best: the nation’s need for evidence on comparative effectiveness in health care. 2007. http://www.iom.edu/~/media/Files/Activity%20Files/Quality/VSRT/ComparativeEffectivenessWhitePaperESF.ashx (accessed Jan 2012).
- 2. Prasad V, Gall V, Cifu A. The frequency of medical reversal. Arch Intern Med 2011; 171: 1675-1676.
- 3. Elshaug AG, Watt AM, Mundy L, Willis CD. Over 150 potentially low-value health care practices. Med J Aust 2012; 197: 556-560. <MJA full text>
- 4. Chang SM, Carey TS, Kato EU, et al. Identifying research needs for improving health care. Ann Intern Med 2012; 157: 439-445.
- 5. Meltzer DO, Hoomans T, Chung JW, Basu A. Minimal modeling approaches to value of information analysis for health research. Med Decis Making 2011; 31: E1-E22.
- 6. Institute of Medicine (US). Initial national priorities for comparative effectiveness research. Washington DC: National Academies Press, 2009. http://www.iom.edu/CMS/3809/63608/71025.aspx (accessed Jan 2012).
- 7. Gartlehner G, Hansen RA, Nissman D, et al. A simple and valid tool distinguished efficacy from effectiveness studies. J Clin Epidemiol 2006; 59: 1040-1048.
- 8. Zalcberg JR. Comparative effectiveness research — a proposal for a new NHMRC funding stream. Med J Aust 2012; 196: 22-23. <MJA full text>
- 9. National Health and Medical Research Council. NHMRC research funding datasets 1990–2012. http://www.nhmrc.gov.au/grants/research-funding-statistics-and-data/funding-datasets (accessed Feb 2013).
- 10. Timbie JW, Fox DS, Van Busum K, Schneider EC. Five reasons that many comparative effectiveness studies fail to change patient care and clinical practice. Health Aff (Millwood) 2012; 31: 2168-2175.
- 11. Atkins D, Kupersmith J. Implementation research: a critical component of realizing the benefits of comparative effectiveness research. Am J Med 2010; 123 (12 Suppl): e38-e45.
- 12. Curran GM, Bauer M, Mittman B, et al. Effectiveness-implementation hybrid designs. Combining elements of clinical effectiveness and implementation research to enhance public health impact. Med Care 2012; 50: 217-226.
- 13. Congressional Budget Office (US). Budget options, volume 1: health care. Washington, DC: CBO, 2008. http://www.cbo.gov/publication/41747 (accessed Dec 2012).
- 14. Bourgeois FT, Murthy S, Mandl KD. Comparative effectiveness research: an empirical study of trials registered in ClinicalTrials.gov. PLoS One 2012; 7: e28820.
- 15. Finfer S, Bellomo R, Boyce N, et al; SAFE Study Investigators. A comparison of albumin and saline for fluid resuscitation in the intensive care unit. N Engl J Med 2004; 350: 2247-2256.
- 16. Cooper BA, Branley P, Bulfone L, et al; IDEAL Study. A randomized, controlled trial of early versus late initiation of dialysis. N Engl J Med 2010; 363: 609-619.
- 17. Bretthauer M, Hoff G. Comparative effectiveness research in cancer screening programmes. BMJ 2012; 344: e2864.
No relevant disclosures.